These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7765405)

  • 21. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.
    Tuckman M; Petersen PJ; Projan SJ
    Microb Drug Resist; 2000; 6(4):277-82. PubMed ID: 11272255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of tetracycline resistance protein transmembrane segment insertion.
    Lewis GS; Jewell JE; Phang T; Miller KW
    Arch Biochem Biophys; 2002 Aug; 404(2):317-25. PubMed ID: 12147271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence of a class E tetracycline resistance gene from Escherichia coli and comparison of related tetracycline efflux proteins.
    Allard JD; Bertrand KP
    J Bacteriol; 1993 Jul; 175(14):4554-60. PubMed ID: 8331085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified method to remove fusion tags from a xylanase of Bacillus sp. HBP8 with HRV 3C protease.
    Xu H; Wang Q; Zhang Z; Yi L; Ma L; Zhai C
    Enzyme Microb Technol; 2019 Apr; 123():15-20. PubMed ID: 30686346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors.
    Zhang Q; Cao R; Liu A; Lei S; Li Y; Yang J; Li S; Xiao J
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4061-4065. PubMed ID: 28778471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli.
    Birch GM; Black T; Malcolm SK; Lai MT; Zimmerman RE; Jaskunas SR
    Protein Expr Purif; 1995 Oct; 6(5):609-18. PubMed ID: 8535153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of human rhinovirus-14 3C protease deamidation isoform.
    Cox GA; Johnson RB; Cook JA; Wakulchik M; Johnson MG; Villarreal EC; Wang QM
    J Biol Chem; 1999 May; 274(19):13211-6. PubMed ID: 10224078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-level tetracycline resistance mediated by efflux pumps Tet(A) and Tet(A)-1 with two start codons.
    Wang W; Guo Q; Xu X; Sheng ZK; Ye X; Wang M
    J Med Microbiol; 2014 Nov; 63(Pt 11):1454-1459. PubMed ID: 25102906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and purification of recombinant 3C proteinase of Coxsackievirus B3.
    Miyashita K; Kusumi M; Utsumi R; Komano T; Satoh N
    Biosci Biotechnol Biochem; 1992 May; 56(5):746-50. PubMed ID: 1369382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of Soluble Expression and Purification of Recombinant Human Rhinovirus Type-14 3C Protease Using Statistically Designed Experiments: Isolation and Characterization of the Enzyme.
    Antoniou G; Papakyriacou I; Papaneophytou C
    Mol Biotechnol; 2017 Oct; 59(9-10):407-424. PubMed ID: 28801725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel bacteriological assay for detection of potential antiviral agents.
    Block TM; Grafstrom RH
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2337-41. PubMed ID: 2088188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.
    Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of functional beta-galactosidase containing the coxsackievirus 3C protease as an internal fusion.
    Windheuser MG; Dwyer S; Dasmahapatra B
    Biochem Biophys Res Commun; 1991 May; 177(1):243-51. PubMed ID: 1904218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of in vitro peptide substrates for human rhinovirus-14 2A protease.
    Wang QM; Johnson RB; Sommergruber W; Shepherd TA
    Arch Biochem Biophys; 1998 Aug; 356(1):12-8. PubMed ID: 9681985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NT*-HRV3CP: An optimized construct of human rhinovirus 14 3C protease for high-yield expression and fast affinity-tag cleavage.
    Abdelkader EH; Otting G
    J Biotechnol; 2021 Jan; 325():145-151. PubMed ID: 33166527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and single-step purification of EGFP and a biotinylated version of the Human Rhinovirus 14 3C protease.
    Youell J; Fordham D; Firman K
    Protein Expr Purif; 2011 Oct; 79(2):258-62. PubMed ID: 21605680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of active-site amino acid residues in the Chiba virus 3C-like protease.
    Someya Y; Takeda N; Miyamura T
    J Virol; 2002 Jun; 76(12):5949-58. PubMed ID: 12021327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids.
    Dragovich PS; Webber SE; Prins TJ; Zhou R; Marakovits JT; Tikhe JG; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Brown EL; Binford SL; Meador JW; Ferre RA; Worland ST
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2189-94. PubMed ID: 10465543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoprocessing: an essential step for expression and purification of enterovirus 71 3C(pro) in Escherichia coli.
    Huang S; Lyu Y; Qing X; Wang W; Tang L; Cheng K; Wang W
    Biotechnol Lett; 2013 Nov; 35(11):1845-52. PubMed ID: 23881322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase.
    Malcolm BA; Lowe C; Shechosky S; McKay RT; Yang CC; Shah VJ; Simon RJ; Vederas JC; Santi DV
    Biochemistry; 1995 Jun; 34(25):8172-9. PubMed ID: 7794931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.